1. In this randomized trial, amivantamab-lazertinib led to significantly longer progression-free survival than osimertinib therapy for mutated advanced non-small-cell lung...
1. Longitudinal results found that children with earlier asthma onset had slower episodic memory development compared to children without asthma....
1. In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival compared to placebo...
1. 36-month overall survival and median event-free survival were significantly greater in the pembrolizumab group compared to control. 2. Grade...
1. Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and symptoms...
1. Early use of mechanical circulatory support did not reduce 6-month all-cause mortality. 2. MCS was associated with increased major...
1. In this randomized controlled trial, among patients with severe hypoxemia, long-term oxygen therapy used for 24 hours per day...
1. Time in hospital was modestly reduced in both intervention groups compared to the control. 2. There was little to...
1. Wearing surgical face masks was superior to not wearing surgical face masks in reducing the risk of respiratory symptoms...
1. Patient data from a Taiwanese national database demonstrated that those who took fluoroquinolones had a greater risk of aortic...
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.
